BY
Therapeutic Areas
Abogen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ARCoV | COVID-19 | Approved (EUA) |
| Undisclosed Candidate 1 | Oncology/Autoimmune | Clinical |
| Undisclosed Candidate 2 | Oncology/Autoimmune | Clinical |
| Drug | Indication | Phase |
|---|---|---|
| ARCoV | COVID-19 | Approved (EUA) |
| Undisclosed Candidate 1 | Oncology/Autoimmune | Clinical |
| Undisclosed Candidate 2 | Oncology/Autoimmune | Clinical |